3.74 score from hupso.pl for:
medimmune.com



HTML Content


Titleleading global biologics r&d | medimmune

Length: 44, Words: 7
Description at medimmune our core therapeutic areas are oncology; respiratory, inflammation & autoimmune, and cardiovascular & metabolic disease.

Length: 141, Words: 17
Keywords pusty
Robots index,follow
Charset UTF-8
Og Meta - Title pusty
Og Meta - Description pusty
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 588
Text/HTML 37.39 %
Headings H1 1
H2 9
H3 3
H4 0
H5 0
H6 0
H1
activating the immune system
H2
the sitc top three: what you need to know about medimmune at the society for immunotherapy of cancer’s annual meeting
medimmune and consortium of four leading uk universities awarded 12 bbsrc biotechnology phd studentships
medmmune out-licenses potential medicine for inflammatory diseases to allergan
astrazeneca to strengthen presence in california with new south san francisco location

life at medimmune
where's the future of biotech? right here in maryland.
medimmune on instagram
join us at medimmune
H3
cookie policy
life at medimmune
medimmune on twitter
H4
H5
H6
strong
b
i
em
Bolds strong 0
b 0
i 0
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 8
Pliki CSS 3
Pliki javascript 5
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 62
Linki wewnętrzne 53
Linki zewnętrzne 9
Linki bez atrybutu Title 60
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

skip to content #main
skip to navigation #navigation
cookie notice. /cookie-notice.html
- - /
breaking new ground /breaking-new-ground.html
breaking new ground /breaking-new-ground.html
life at medimmune /breaking-new-ground/life-at-medimmune.html
biological /about-us/biological.html
our science /our-science.html
our science /our-science.html
pipeline /our-science/pipeline.html
technologies /our-science/technologies.html
publications /our-science/publications.html
partnering /our-science/partnering.html
our therapy areas /our-therapy-areas.html
our therapy areas /our-therapy-areas.html
oncology /our-therapy-areas/oncology.html
respiratory, inflammation & autoimmunity /our-therapy-areas/respiratory-inflammation-and-autoimmunity.html
cardiovascular & metabolic disease /our-therapy-areas/cardiovascular-and-metabolic-disease.html
infectious disease /our-therapy-areas/infectious-disease-vaccines.html
about us /about-us.html
about us /about-us.html
gaithersburg, md /about-us/gaithersburg-md.html
cambridge, uk /about-us/cambridge-uk.html
mountain view, ca /about-us/mountain-view-ca.html
leadership /about-us/leadership.html
sustainability /about-us/sustainability.html
careers /about-us/careers.html
media /about-us/media.html
contact us /about-us/contact-us.html
learn more /our-therapy-areas/oncology.html
learn more /about-us/media/the-sitc-top-three-what-you-need-to-know-about-medimmune-at-the-society-for-immunotherapy-of-cancers-annual-meeting.html
-

life at medimmune

/breaking-new-ground/life-at-medimmune.html
meet our people /breaking-new-ground.html
check out our facilities /about-us/gaithersburg-md.html
explore our technology /our-science/technologies.html

medimmune and consortium of four leading uk universities awarded 12 bbsrc biotechnology phd studentships

/about-us/media/medimmune-and-consortium-of-four-leading-uk-universities-28112016.html

medmmune out-licenses potential medicine for inflammatory diseases to allergan

/about-us/media/medimmune-out-licenses-potential-medicine-for-inflammatory-diseases-to-allergan-031020161.html

astrazeneca to strengthen presence in california with new south san francisco location

/about-us/media/astrazeneca-to-strengthen-presence-in-california-with-new-south-san-francisco-location-27092016.html

where's the future of biotech? right here in maryland.

the first ever maryland regional biotech forum hosted by medimmune drew more than 400 leaders of local life sciences companies, academic institutions, nonprofit organizations, investment funds and government entities. the goal: outline concrete steps toward our commitment to make the maryland region one of the top three biotech hubs in the united states by 2023.
/breaking-new-ground/the-future-of-biotech-right-here-in-maryland-20150408.html
medimmune careers /about-us/careers.html
media /about-us/media.html
privacy & terms /privacy-and-terms.html
cookies notice /cookie-notice.html
site map /sitemap.html
medimmune /
cancel #
continue #
? #!
i disagree #
i agree #
? #!
? #!

Linki zewnętrzne

https://www.instagram.com/medimmunelife
- https://www.twitter.com/astrazeneca
@astrazeneca https://www.twitter.com/astrazeneca

so much #oncology science to cover this month - we’ll be at #ash16 #wclc2016 & #sabcs16. follow along for updates! https://t.co/rgkokxbvtf

-
https://www.twitter.com/statuses/804759877411307520
careers https://careers.astrazeneca.com/medimmune
astrazeneca https://www.astrazeneca.com/
twitter https://twitter.com/medimmune
linkedin https://www.linkedin.com/company/medimmune
instagram https://www.instagram.com/medimmunelife/

Zdjęcia

Zdjęcia 10
Zdjęcia bez atrybutu ALT 6
Zdjęcia bez atrybutu TITLE 10
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/etc/designs/mm/img/logo-mm-large.png
/etc/designs/mm/img/logo-mm-small.png
/content/dam/medimmune/about-us/media/articles/pdl1 biopsy.jpg/_jcr_content/renditions/original
/content/dam/medimmune/about-us/media/life_at_medimmune_new.png/_jcr_content/renditions/cq5dam.web.100.square.life_at_medimmune_new.png
/content/dam/medimmune/homepage/cambridge lab 1.jpg/_jcr_content/renditions/cq5dam.web.320.cambridge lab 1.jpg
/content/dam/medimmune/about-us/media/articles/tissue phenomics.png/_jcr_content/renditions/cq5dam.web.320.tissue phenomics.png
/content/dam/medimmune/about-us/media/multimedia library/dsc5816-1.png/_jcr_content/renditions/cq5dam.web.320.dsc5816-1.png
/content/dam/medimmune/homepage/life_at_medimmune.jpg/_jcr_content/renditions/cq5dam.web.320.life_at_medimmune.jpg
https://pbs.twimg.com/profile_images/837494857/aztwitter_normal.png
https://pbs.twimg.com/media/cysu14qviaac06h.jpg:small

Zdjęcia bez atrybutu ALT

/content/dam/medimmune/about-us/media/life_at_medimmune_new.png/_jcr_content/renditions/cq5dam.web.100.square.life_at_medimmune_new.png
/content/dam/medimmune/homepage/cambridge lab 1.jpg/_jcr_content/renditions/cq5dam.web.320.cambridge lab 1.jpg
/content/dam/medimmune/about-us/media/articles/tissue phenomics.png/_jcr_content/renditions/cq5dam.web.320.tissue phenomics.png
/content/dam/medimmune/about-us/media/multimedia library/dsc5816-1.png/_jcr_content/renditions/cq5dam.web.320.dsc5816-1.png
https://pbs.twimg.com/profile_images/837494857/aztwitter_normal.png
https://pbs.twimg.com/media/cysu14qviaac06h.jpg:small

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

skip to content skip to navigation cookie policy this website uses cookies to help us give you the best experience when you visit. by using this website you consent to our use of these cookies. find out more about how we use cookies and how to manage them by reading our cookie notice. close menu search breaking new ground breaking new ground life at medimmune biological our science our science pipeline technologies publications partnering our therapy areas our therapy areas oncology respiratory, inflammation & autoimmunity cardiovascular & metabolic disease infectious disease about us about us gaithersburg, md cambridge, uk mountain view, ca leadership sustainability careers media contact us search activating the immune system learn more featured article the sitc top three: what you need to know about medimmune at the society for immunotherapy of cancer’s annual meeting as scientists from around the globe gather this week at the national harbor, md, for the society for immunotherapy of cancer (sitc) annual meeting, one buzz word seems apparent: innovation. but with so much new data, how can you pinpoint just what to watch? as a leader in cancer immunotherapy, medimmune, the global biologics research and development arm of astrazeneca, presents our top three things you need to know about our posters and presentations: learn more life at medimmune meet our people check out our facilities explore our technology medimmune and consortium of four leading uk universities awarded 12 bbsrc biotechnology phd studentships medmmune out-licenses potential medicine for inflammatory diseases to allergan astrazeneca to strengthen presence in california with new south san francisco location life at medimmune where's the future of biotech? right here in maryland. the first ever maryland regional biotech forum hosted by medimmune drew more than 400 leaders of local life sciences companies, academic institutions, nonprofit organizations, investment funds and government entities. the goal: outline concrete steps toward our commitment to make the maryland region one of the top three biotech hubs in the united states by 2023. 28 july 2015 medimmune on instagram medimmune on twitter medimmune retweeted astrazeneca @astrazeneca so much #oncology science to cover this month - we’ll be at #ash16 #wclc2016 & #sabcs16. follow along for updates! https://t.co/rgkokxbvtf join us at medimmune our great place to work strategic initiative offers a dynamic environment that fosters collaboration and innovation. we attract top minds, and we do what it takes to nurture and build talent. medimmune careers careers media privacy & terms cookies notice site map astrazeneca twitter linkedin instagram medimmune ©medimmune 2015 you are now leaving medimmune.com you have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. medimmune provides this link as a service to website visitors. medimmune is not responsible for the privacy policy of any third party websites. we encourage you to read the privacy policy of every website you visit. click ‘cancel’ to return to medimmune’s site or ‘continue’ to proceed. cancel continue ? important notice for users you are about to access medimmune historic archive material. any reference in these archives to medimmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. please refer to your approved national product label (smpc) for current product information. i have read this warning and will not be using any of the contained product information for clinical purposes. i disagree i agree ? ?


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 582

One word

Two words phrases

Three words phrases

the - 5.15% (30)
immune - 3.61% (21)
medimmune - 3.44% (20)
our - 2.92% (17)
for - 2.58% (15)
and - 2.23% (13)
you - 2.23% (13)
out - 1.89% (11)
not - 1.72% (10)
are - 1.37% (8)
site - 1.37% (8)
can - 1.03% (6)
about - 1.03% (6)
this - 1.03% (6)
use - 1.03% (6)
cookie - 1.03% (6)
therapy - 0.86% (5)
astrazeneca - 0.86% (5)
website - 0.86% (5)
product - 0.86% (5)
more - 0.69% (4)
now - 0.69% (4)
new - 0.69% (4)
life - 0.69% (4)
biotech - 0.69% (4)
science - 0.69% (4)
top - 0.69% (4)
cookies - 0.69% (4)
immunotherapy - 0.52% (3)
privacy - 0.52% (3)
link - 0.52% (3)
meet - 0.52% (3)
leader - 0.52% (3)
three - 0.52% (3)
maryland - 0.52% (3)
know - 0.52% (3)
notice - 0.52% (3)
cancer - 0.52% (3)
careers - 0.52% (3)
any - 0.52% (3)
what - 0.52% (3)
policy - 0.52% (3)
data - 0.52% (3)
how - 0.52% (3)
search - 0.52% (3)
present - 0.52% (3)
information - 0.52% (3)
disease - 0.52% (3)
read - 0.52% (3)
continue - 0.34% (2)
have - 0.34% (2)
twitter - 0.34% (2)
will - 0.34% (2)
archive - 0.34% (2)
current - 0.34% (2)
take - 0.34% (2)
third - 0.34% (2)
party - 0.34% (2)
responsible - 0.34% (2)
cancel - 0.34% (2)
refer - 0.34% (2)
label - 0.34% (2)
that - 0.34% (2)
skip - 0.34% (2)
instagram - 0.34% (2)
society - 0.34% (2)
uses - 0.34% (2)
visit. - 0.34% (2)
using - 0.34% (2)
these - 0.34% (2)
breaking - 0.34% (2)
ground - 0.34% (2)
areas - 0.34% (2)
oncology - 0.34% (2)
media - 0.34% (2)
learn - 0.34% (2)
sitc - 0.34% (2)
need - 0.34% (2)
annual - 0.34% (2)
2015 - 0.34% (2)
meeting - 0.34% (2)
national - 0.34% (2)
content - 0.34% (2)
one - 0.34% (2)
innovation. - 0.34% (2)
with - 0.34% (2)
much - 0.34% (2)
technology - 0.34% (2)
here - 0.34% (2)
ever - 0.34% (2)
leaders - 0.34% (2)
region - 0.34% (2)
agree - 0.34% (2)
at medimmune - 0.69% (4)
of the - 0.52% (3)
top three - 0.52% (3)
life at - 0.52% (3)
skip to - 0.34% (2)
for the - 0.34% (2)
in the - 0.34% (2)
medimmune on - 0.34% (2)
you to - 0.34% (2)
responsible for - 0.34% (2)
third party - 0.34% (2)
privacy policy - 0.34% (2)
the privacy - 0.34% (2)
policy of - 0.34% (2)
you visit. - 0.34% (2)
you are - 0.34% (2)
to medimmune - 0.34% (2)
not be - 0.34% (2)
out our - 0.34% (2)
a leader - 0.34% (2)
this website - 0.34% (2)
careers media - 0.34% (2)
website you - 0.34% (2)
breaking new - 0.34% (2)
new ground - 0.34% (2)
our science - 0.34% (2)
our therapy - 0.34% (2)
therapy areas - 0.34% (2)
you need - 0.34% (2)
of cancer - 0.34% (2)
to know - 0.34% (2)
at the - 0.34% (2)
society for - 0.34% (2)
immunotherapy of - 0.34% (2)
the society - 0.34% (2)
for immunotherapy - 0.34% (2)
product label - 0.34% (2)
life at medimmune - 0.52% (3)
need to know - 0.34% (2)
the society for - 0.34% (2)
society for immunotherapy - 0.34% (2)
to know about - 0.34% (2)
the privacy policy - 0.34% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.